Skip to main content
Caplight Logo









Gliknik Inc

Gliknik Inc

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://www.gliknik.com/

Last Round

VC Round

Sep 17, 2026

Total Funding Raised

$68.89M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Gliknik Inc is a biopharmaceutical company that discovers and develops innovative biologics for the treatment of cancer and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalmonoclonal antibodiesdrug discoverybispecific antibodyimmune-modulating therapybiotechantibody engineeringclinical-stage biotechautoimmune disease treatmentcancer therapeuticslicensing partnershipbiologicsr&d pipelinemilestone payments

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gliknik Inc Comparables

Compare Gliknik Inc with similar companies based on industry and business-model similarity.

Gliknik Inc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biond Biologics
78%
NovelMed Therapeutics
77%
Lyvgen Biopharma
77%

Gliknik Inc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 17, 2026
Early FundingJul 7, 2023
Series CJun 24, 2021
Corporate FundingFeb 19, 2019
Corporate FundingSep 30, 2013
Series B
Oct 8, 2012

Gliknik Inc Investors

Notable investors and investment history

Gliknik Inc investors
InvestorRounds
William Harris InvestorsSeries A
National Cancer InstituteGrant
Baxter VenturesSeries B
RDA VenturesSeries A, Series C
First InSeries C
LifeTech Developments FundSeries B
PfizerCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 17, 2026

    $15M raised in early stage VC round.

  • Jul 25, 2026

    Monthly visitors grew 109% MoM, reaching 2.1K.

Gliknik Inc Filings

Explore SEC and related filing metadata, where available.

Gliknik Inc filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Gliknik Inc's valuation, stock price, and market status.

Is Gliknik Inc a public or private company?

Gliknik Inc is a private company.

What is the current stock price of Gliknik Inc?

Gliknik Inc is a private company, so its shares have no public market price. Caplight tracks Gliknik Inc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Gliknik Inc worth (valuation)?

Valuation information for Gliknik Inc is not publicly available.

Can I buy Gliknik Inc stock?

Gliknik Inc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Gliknik Inc's last funding round?

Gliknik Inc's most recent funding round was VC Round on September 17, 2026.

Who are the main investors in Gliknik Inc?

Key investors in Gliknik Inc include Baxter Ventures, First In.

Will Gliknik Inc IPO soon?

No public IPO plans have been announced for Gliknik Inc.

How can I track Gliknik Inc secondary market activity?

Caplight tracks bids, offers, and trades in Gliknik Inc's shares on secondary markets.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range2
Year Founded2007
Last FundingSep 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?